The FDA employs various forms of written communication to disseminate information:
1. Guidance Documents: These provide detailed instructions on regulatory expectations for various aspects of drug development, clinical trials, and post-market surveillance.
2. Safety Communications: Issued to alert the public and healthcare communities about potential health risks associated with products, including drugs and medical devices.
3. Press Releases and Public Statements: Used to inform the public about significant regulatory actions, approvals, or safety concerns.
4. Scientific Publications: The FDA often publishes research findings in peer-reviewed journals, contributing to the broader scientific literature.
